Modulation of peripheral sympathetic nerve transmission.

[1]  Chapman Cb.  Letter: Accelerated students. , 1975 .

[2]  J. Holaday,et al.  Opiate antagonists: a role in the treatment of hypovolemic shock. , 1979, Science.

[3]  L. Cregler,et al.  Cardiovascular dangers of cocaine abuse. , 1986, The American journal of cardiology.

[4]  M. Goldberg,et al.  Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor. , 1983, Pharmacological reviews.

[5]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[6]  R. Tsien,et al.  Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons. , 1988, Science.

[7]  P. Sullivan,et al.  Effects of clonidine on central and peripheral nerve tone in primary hypertension. , 1986, Hypertension.

[8]  B. W. East,et al.  Captopril in heart failure. A double blind controlled trial. , 1984, British heart journal.

[9]  T. Hökfelt,et al.  The noradrenaline content of the varicosities of sympathetic adrenergic nerve terminals in the rat. , 1966, Acta physiologica Scandinavica.

[10]  Kenter Gg.  Placebo-controlled, double-blind methods. , 1980 .

[11]  H. Lal,et al.  Clonidine in the treatment of narcotic addiction , 1983 .

[12]  R. Magorien,et al.  Regional Hemodynamic Effects of Clonidine in Congestive Heart Failure , 1985, Journal of cardiovascular pharmacology.

[13]  J. Holaday,et al.  Experimental endotoxin shock: the pathophysiologic function of endorphins and treatment with opiate antagonists. , 1980, The Journal of infectious diseases.

[14]  B. Fredholm,et al.  Are methylxanthine effects due to antagonism of endogenous adenosine , 1979 .

[15]  J. Cohn,et al.  The neurohumoral axis in congestive heart failure. , 1984, Annals of internal medicine.

[16]  S. Z. Langer.  Presynaptic regulation of the release of catecholamines. , 1980, Pharmacological reviews.

[17]  M. Dubocovich,et al.  PHARMACOLOGICAL DIFFERENTIATION OF PRESYNAPTIC INHIBITORY α‐ADRENOCEPTORS AND OPIATE RECEPTORS IN THE CAT NICTITATING MEMBRANE , 1980, British journal of pharmacology.

[18]  J. Holaday,et al.  Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock , 1978, Nature.

[19]  S. Z. Langer.  Presynaptic receptors and modulation of neurotransmission: pharmacological implications and therapeutic relevance , 1980, Trends in Neurosciences.

[20]  J. Holaday,et al.  Endorphins in experimental spinal injury: Therapeutic effect of naloxone , 1981, Annals of neurology.

[21]  A. Hollister,et al.  Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. , 1983, The American journal of medicine.

[22]  A. Schömig,et al.  Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. , 1987, Circulation research.

[23]  J. Cohn,et al.  The effects of bromocriptine in patients with congestive heart failure. , 1983, American heart journal.

[24]  J. Ménard,et al.  HYPERTENSIVE CRISIS IN PATIENT WITH PHÆOCHROMOCYTOMA GIVEN METOCLOPRAMIDE , 1976, The Lancet.

[25]  S. Kalsner.  Limitations of presynaptic adrenoceptor theory: the characteristics of the effects of noradrenaline and phenoxybenzamine on stimulation-induced efflux of [3H]noradrenaline in vas deferens. , 1980, The Journal of pharmacology and experimental therapeutics.

[26]  J. Holaday,et al.  Comparison of early and late naloxone treatment in experimental spinal injury , 1982, Neurology.

[27]  W. Mitch,et al.  PRESSOR EFFECT OF NALOXONE IN SEPTIC SHOCK , 1981, The Lancet.

[28]  P. Vanhoutte,et al.  Local modulation of adrenergic neuroeffector interaction in the blood vessel well. , 1981, Physiological reviews.

[29]  S. Vatner,et al.  Direct versus indirect pressor and vasoconstrictor actions of angiotensin in conscious dogs. , 1985, Hypertension.

[30]  J. Cohn,et al.  The autonomic nervous system in congestive heart failure. , 1986, Annual review of medicine.

[31]  Phillis Jw,et al.  Adenosine, adenylate cyclase, and transmitter release. , 1985 .

[32]  J. Axelrod.  The fate of noradrenaline in the sympathetic neurone. , 1973, Harvey lectures.

[33]  O. M. Brown,et al.  Parasympathetic effects on in vivo rat heart can be regulated through an alpha 1-adrenergic receptor. , 1987, Circulation research.

[34]  A. D. Smith,et al.  Summing up: some implications of the neuron as a secreting cell. , 1971, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[35]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[36]  B. Ljung,et al.  Increased noradrenaline release in rat portal vein during sympathetic nerve stimulation due to activation of presynaptic beta-adrenoceptors by noradrenaline and adrenaline. , 1978, European journal of pharmacology.

[37]  B. Wallin,et al.  The Antihypertensive Mechanism of Clonidine in Man: Evidence Against a Generalized Reduction of Sympathetic Activity , 1981, Hypertension.

[38]  I. Kopin,et al.  Effects of clonidine on central and peripheral catecholamine metabolism , 1984, Clinical pharmacology and therapeutics.

[39]  W. McCabe,et al.  NALOXONE VERSUS PLACEBO IN TREATMENT OF SEPTIC SHOCK , 1985, The Lancet.

[40]  D. Nutt,et al.  NIH conference. Alcohol withdrawal and noradrenergic function. , 1987, Annals of internal medicine.

[41]  J. Schadt,et al.  Endogenous opiate peptides may limit norepinephrine release during hemorrhage. , 1985, The Journal of pharmacology and experimental therapeutics.

[42]  B B Fredholm,et al.  Modulation of neurotransmission by purine nucleotides and nucleosides. , 1980, Biochemical pharmacology.

[43]  B. Walsh,et al.  Cigarette craving, smoking withdrawal, and clonidine. , 1984, Science.

[44]  H. Gavras.  How does salt raise blood pressure? A hypothesis. , 1986, Hypertension.

[45]  N. Imai,et al.  The role of endogenous opioids in congestive heart failure: effects of nalmefene on systemic and regional hemodynamics in dogs. , 1987, Circulation.

[46]  S. Z. Langer,et al.  Presynaptic regulation of catecholamine release. , 1974, Biochemical pharmacology.

[47]  H. Majewski,et al.  Adrenaline mediates a positive feedback loop in noradrenergic transmission: its possible role in development of hypertension. , 1984, Clinical and experimental hypertension. Part A, Theory and practice.

[48]  R. Berne,et al.  Dromotropic effects of adenosine and adenosine antagonists in the treatment of cardiac arrhythmias involving the atrioventricular node. , 1984, Circulation.

[49]  T. Vargish,et al.  Opiate receptors and endorphins in the pathophysiology of hemorrhagic shock. , 1981, Surgery.

[50]  J. Holaday,et al.  Endorphins in Experimental Spinal Injury: Therapeutic Effects of Naloxone , 1982 .